Full Length Research Paper
References
|
Alshrefy AJ, Alwohaaibi RN, Alhazzaa SA, Almaimoni RA, Al Musailet LI, AL Qahtani SY, Alshahrani MS (2022). Incidence of Bacterial and Fungal Secondary Infections in COVID-19 Patients Admitted to the ICU. International Journal of General Medicine 15:7475-7485. |
|
|
Arastehfar A, Shaban T, Zarrinfar H, Roudbary M, Ghazanfari M, Hedayati MT, Sedaghat A, Llkit M, Najafzadeh MJ, Perlin DS (2021). Candidemia among Iranian Patients with Severe COVID-19 Admitted to ICUs. Journal of Fungi (Basel) 7(4):280. |
|
|
Brachman PS (2003). Infectious diseases-Past, present, and future. International Journal of Epidemiology. Pmid:14559728 |
|
|
Cataño-Correa JC, Cardona-Arias JA, Porras Mancilla JP, García MT (2021). Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020. PLoS ONE 16(7):e0254671. |
|
|
Clancy CJ, Nguyen MH (2017). Emergence of candida auris: An international call to arms. Clinical Infectious Diseases 64(2):141-143. |
|
|
Clinical Laboratory Standard Institute (CLSI) M100 31st Edition (2021). Performance Standards for Antimicrobial Susceptibility Testing. VITEK® 2 Systems 7.01 and 8.01 software. Available at: |
|
|
Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE (2020). Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clinical Infectious Diseases 71(6):1367-1376. |
|
|
GAFFI (2018). Global Fund for Fungal Infections. |
|
|
Garcia-Vidal C, Sanjuan G, Moreno-Garcia E (2021). Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clinical Microbiology and Infection 27(1):83-88. |
|
|
Hughes S, Troise O, Donaldson H, Mughal N, Moore LS (2020). Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary care setting. Clinical Microbiology and Infection 26:1395-1399. |
|
|
Kubin JC, McConville HT, Dietz D, Zucker J, May M, Nelson B, Istorico E, Bartram L, Small-Saunders J, Sobieszczyk EM, Gomez-Simmonds A, Uhlemann A (2021). Characterization of Bacterial and Fungal Infections in Hospitalized Patients with Coronavirus Disease 2019 and Factors Associated with Health Care-Associated Infections. Open Forum Infectious Disease 8(6):ofab201. |
|
|
Lansbury L, Lim B, Baskaran V, Lim WS (2020). Co-infections in people with COVID-19: a systematic review and meta-analysis. Journal of Infection 81:266-75. |
|
|
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, ZHU N, Bi Y, Ma X, Zhan F, Wang L (2020). Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565-574. |
|
|
Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA (2014). Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of healthcare-associated infections. The New England Journal of Medicine 370(13):1198-1208. |
|
|
Morovati H, Eslami S, Farzaneh bonab H, Kord M, Darabian S (2022). bacterial and fungal coinfections among patients with COVID-19 in Zanjan, Northwest of Iran; a single center observational with meta-analysis of the literature. Iranian Journal of Microbiology 14(5):624-635. |
|
|
Nag VL, Kaur N (2021). Superinfections in COVID-19 Patients: Role of Antimicrobials. Dubai Medical Journal 4(2). |
|
|
PLATELIA™ ASPERGILLUS EIA: immunoenzymatically sandwich microplate assay for the detection of aspergillus galactomannan antigen in serum. Product No. 62796 (96 Tests). |
|
|
Ramanan P, Wengenack NL, Theel ES (2017). Laboratory diagnostics for fungal infections: a review of current and future diagnostic assays. Clinics in Chest Medicine 38(3):535-554. |
|
|
Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M (2020). Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clinical Infectious Diseases 71(9):2459-2468. |
|
|
Søvik S, Barrat-Due A, Kåsine T, Olasveengen T, Strand MW, Tveita AA, Berdal JE, Lehre MA, Lorentsen T, Heggelund L, Stenstad T, Ringstad J, Müller F, Aukrust P, Holter JC, Nordøy I (2022). Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation. Journal of Infection 85(1):57-63. |
|
|
Thompson ML, Myers JE, Kriebel D (1998). Prevalence odds ratio or prevalence ratio in the analysis of cross-sectional data: What is to be done? Journal of Occupational and Environmental Medicine 55(4):272-277. |
|
|
Verma N, Singh S, Taneja S, Duseja A, Singh V, Dhiman RK (2019). Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections. Liver International 39:503-513. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
